Margetuximab/Vinorelbine Regimen

**Semantic type:** Therapeutic or Preventive Procedure

**Definition:** A regimen consisting of vinorelbine and margetuximab that can be used for the treatment of recurrent and metastatic HER-2 (EGFR2; ErbB2)-positive breast cancer.

**Synonyms:** - Margenza/Navelbine - Margetuximab-Vinorelbine - Margetuximab-Vinorelbine Regimen - Margetuximab-cmkb/Vinorelbine Regimen - Margetuximab/Vinorelbine - Vinorelbine Plus Margetuximab - Vinorelbine and Margetuximab - Vinorelbine-Margetuximab - Vinorelbine/Margetuximab - Vinorelbine/Margetuximab Regimen